School of Medicine

Christopher D. Smyser, MD, a renowned pediatric neurologist specializing in neonatal neurology and infant brain development, has been appointed director of the Division of Pediatric & Developmental Neurology in the Department of Neurology at WashU Medicine.

In a study published in Nature Neuroscience, researchers at WashU Medicine showed in mice that Alzheimer’s disease upended the daily activity patterns of hundreds of genes in cells that regulate key functions in the brain.

Eva Klinman, MD, PhD, an instructor in the Department of Neurology at WashU Medicine, has been named a 2025 STAT Wunderkind by STAT News for her exceptional contributions to understanding the mechanisms of brain aging and neurodegeneration.

Pamela K. Woodard, MD, head of the Department of Radiology and director of Mallinckrodt Institute of Radiology at WashU Medicine, is among 100 new members elected this year to the National Academy of Medicine, one of the highest honors in health and medicine.

At the Washington University in St. Louis Board of Trustees meeting Sept. 19, numerous faculty members were appointed, promoted or granted tenure, with most taking effect that day.

Timothy J. Eberlein, MD, director of Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been active within the American College of Surgeons for many years, including serving as chair of the board from 2022-2023.

A new study by WashU researchers showed that family fights and peer bullying outweighed other risk factors for depression and other mental health problems, with adolescent girls suffering more than boys.

Sidharth Puram, MD, PhD, a distinguished physician-scientist specializing in head and neck cancer surgery, has been named the head of the Department of Otolaryngology — Head & Neck Surgery at WashU Medicine.

The St. Louis Children’s Hospital and WashU Medicine Heart Center has become one of only eight programs in the nation to perform a rare, lifesaving procedure in which one donor’s organ is transplanted into a patient, who then becomes a donor for another patient.

Prognosia, a biotech startup that harnesses AI-driven software to analyze mammograms to improve breast cancer risk prediction, was created by Graham Colditz, MD, DrPH, and Shu (Joy) Jiang, PhD, both at WashU Medicine.